| Baseline | Treatment phase | Follow-up phase | |||
---|---|---|---|---|---|---|
 | −1 week | 0 day | 4 weeks | 8 weeks | 12 weeks | 16 weeks |
Patients | Â | Â | Â | Â | Â | Â |
Inclusion and exclusion | * | Â | Â | Â | Â | Â |
Allocate informed consent | * | Â | Â | Â | Â | Â |
Sign the informed consent | Â | * | Â | Â | Â | Â |
Medical history | * | Â | Â | Â | Â | Â |
Laboratory test | * | Â | Â | Â | Â | Â |
Randomization | Â | * | Â | Â | Â | Â |
Intervention | Â | Â | Â | Â | Â | Â |
PC6 group (n = 20) |  | 12 sessions of acupuncture |  |  |  | |
Non-acupoint point group (n = 20) |  |  |  |  | ||
Comparison | Â | Â | Â | Â | Â | Â |
Control group (n = 20) |  |  |  |  |  |  |
Outcomes | Â | Â | Â | Â | Â | Â |
Angina attacks in four weeks | Â | Â | * | * | * | * |
VAS | Â | * | * | * | * | * |
Dosage of nitroglycerin | Â | * | * | * | * | * |
6-MWT | Â | * | * | Â | Â | Â |
SAQ | Â | * | * | * | Â | Â |
SAS | Â | * | * | * | Â | Â |
SDS | Â | * | * | * | Â | Â |
The incidence of cardiovascular episode during the 4Â months | Â | Â | Â | Â | Â | * |
Dynamic ECG Observation of the changes of ST-T | Â | * | * | Â | Â | Â |
Clinic evaluation | Â | Â | Â | Â | Â | Â |
Safety of electro-acupuncture | Â | Â | * | Â | Â | * |
Adverse events | Â | Â | * | * | * | * |
Patient’s compliance |  |  | * |  |  |  |
Reasons of drop-out withdrawals | Â | Â | * | Â | Â | Â |
Laboratory evaluation | Â | Â | Â | Â | Â | Â |
Blood collection | Â | * | * | Â | Â | * |
RNA & DNA extraction | Â | * | * | Â | Â | * |
RNA-Seq & ChIP-Seq data analysis | Â | Â | * | Â | Â | * |